manufacturing license
AstraZeneca Ends Manufacturing License at Indian Plant and Exits Site as Part of Global Strategy
AstraZeneca; India; manufacturing license; site exit; Bangalore plant; contract manufacturing; global strategy; pharmaceutical industry